Rapidly progressive classic Kaposi sarcoma in an adolescent: response to interferon alfa therapy and biological correlates.
Guttman-Yassky
E
E
Kra-Oz
Z
Z
Cohen
A
A
Sattinger
Y
Y
Rot
T
T
Sarid
R
R
Bergman
R
R
D000293:Adolescent; D000956:Antigens, Viral / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism; D018450:Disease Progression; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D009687:Nuclear Proteins / Q000378:metabolism; D011994:Recombinant Proteins; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
D000956:Antigens, Viral; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009687:Nuclear Proteins; D011994:Recombinant Proteins; C109540:latency-associated nuclear antigen